{
    "organizations": [],
    "uuid": "79ce301f14501e23776a5d5c3fa119cb30b399df",
    "author": "",
    "url": "https://www.reuters.com/article/brief-adamis-pharmaceuticals-updates-sym/brief-adamis-pharmaceuticals-updates-symjepi-commercialization-plans-idUSASB0C7AI",
    "ord_in_thread": 0,
    "title": "BRIEF-Adamis Pharmaceuticals Updates Symjepi Commercialization Plans",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 15 PM / in 9 minutes BRIEF-Adamis Pharmaceuticals Updates Symjepi Commercialization Plans Reuters Staff Feb 23 (Reuters) - Adamis Pharmaceuticals Corp: * ADAMIS PHARMACEUTICALS UPDATES SYMJEPI COMMERCIALIZATION PLANS * ADAMIS PHARMACEUTICALS CORP - COMMERCIALIZATION PROCESS FOR SYMJEPI IS STILL ONGOING * ADAMIS PHARMACEUTICALS CORP - NOW IN DISCUSSIONS WITH TWO POTENTIAL PARTNERS FOR SYMJEPI COMMERCIALIZATION Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)",
    "published": "2018-02-23T16:12:00.000+02:00",
    "crawled": "2018-02-23T16:33:31.025+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "minute",
        "pharmaceutical",
        "update",
        "symjepi",
        "commercialization",
        "plan",
        "reuters",
        "staff",
        "feb",
        "reuters",
        "adamis",
        "pharmaceutical",
        "corp",
        "adamis",
        "pharmaceutical",
        "update",
        "symjepi",
        "commercialization",
        "plan",
        "adamis",
        "pharmaceutical",
        "corp",
        "commercialization",
        "process",
        "symjepi",
        "still",
        "ongoing",
        "adamis",
        "pharmaceutical",
        "corp",
        "discussion",
        "two",
        "potential",
        "partner",
        "symjepi",
        "commercialization",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}